tiprankstipranks
OrbusNeich Medical Group Holdings Limited (HK:6929)
:6929
Hong Kong Market
6929
OrbusNeich Medical Group Holdings Limited
RESEARCH TOOLSreports
Want to see HK:6929 full AI Analyst Report?

OrbusNeich Medical Group Holdings Limited (6929) Ratios

1 Followers

OrbusNeich Medical Group Holdings Limited Ratios

HK:6929's free cash flow for Q4 2025 was $0.69. For the 2025 fiscal year, HK:6929's free cash flow was decreased by $ and operating cash flow was $0.24. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 10.54 10.54 11.77 9.77 13.20
Quick Ratio
 8.51 8.51 9.93 8.60 11.96
Cash Ratio
 6.57 6.57 8.09 7.18 9.62
Solvency Ratio
 1.16 1.17 1.14 1.21 0.79
Operating Cash Flow Ratio
 0.64 0.59 0.43 0.65 0.98
Short-Term Operating Cash Flow Coverage
 9.51 8.73 0.00 5.44 0.00
Net Current Asset Value
$ 311.91M$ 311.91M$ 324.82M$ 307.24M$ 285.78M
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 <0.01 0.02 0.01
Debt-to-Equity Ratio
 <0.01 <0.01 0.01 0.02 0.01
Debt-to-Capital Ratio
 <0.01 <0.01 0.01 0.02 0.01
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.10 1.10 1.10 1.11 1.09
Debt Service Coverage Ratio
 16.07 15.68 156.16 11.29 16.29
Interest Coverage Ratio
 472.18 236.54 147.09 281.26 14.40
Debt to Market Cap
 <0.01 <0.01 0.00 <0.01 0.00
Interest Debt Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Net Debt to EBITDA
 -5.07 -5.02 -6.65 -4.60 -8.30
Profitability Margins
Gross Profit Margin
67.85%67.85%69.76%69.22%67.57%
EBIT Margin
21.80%21.80%21.22%32.34%17.00%
EBITDA Margin
23.48%23.71%22.40%35.07%19.83%
Operating Profit Margin
22.02%22.02%19.63%25.96%15.40%
Pretax Profit Margin
26.09%26.09%25.84%32.25%15.93%
Net Profit Margin
23.22%23.22%24.20%29.29%13.51%
Continuous Operations Profit Margin
23.29%23.29%24.28%29.29%13.51%
Net Income Per EBT
88.98%88.98%93.66%90.82%84.86%
EBT Per EBIT
118.49%118.49%131.65%124.26%103.41%
Return on Assets (ROA)
9.25%9.25%9.21%10.99%5.27%
Return on Equity (ROE)
10.20%10.15%10.10%12.23%5.73%
Return on Capital Employed (ROCE)
9.47%9.47%8.05%10.66%6.44%
Return on Invested Capital (ROIC)
8.41%8.41%7.53%9.53%5.44%
Return on Tangible Assets
9.74%9.74%9.66%11.54%5.37%
Earnings Yield
9.82%10.92%10.05%6.00%2.27%
Efficiency Ratios
Receivables Turnover
 3.43 3.43 3.17 4.05 4.23
Payables Turnover
 12.35 12.35 7.26 9.84 10.91
Inventory Turnover
 0.86 0.86 0.88 1.14 1.51
Fixed Asset Turnover
 3.98 3.98 5.95 8.33 10.29
Asset Turnover
 0.40 0.40 0.38 0.38 0.39
Working Capital Turnover Ratio
 0.55 0.56 0.51 0.51 0.54
Cash Conversion Cycle
 501.13 501.13 479.22 372.18 294.66
Days of Sales Outstanding
 106.47 106.47 115.26 90.06 86.23
Days of Inventory Outstanding
 424.21 424.21 414.27 319.22 241.87
Days of Payables Outstanding
 29.55 29.55 50.30 37.10 33.44
Operating Cycle
 530.68 530.68 529.52 409.28 328.10
Cash Flow Ratios
Operating Cash Flow Per Share
 0.03 0.02 0.02 0.03 0.03
Free Cash Flow Per Share
 0.01 <0.01 <0.01 0.02 0.03
CapEx Per Share
 0.01 0.02 0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 0.56 0.06 0.14 0.68 0.86
Dividend Paid and CapEx Coverage Ratio
 0.84 0.43 0.60 3.08 7.03
Capital Expenditure Coverage Ratio
 2.27 1.06 1.16 3.08 7.03
Operating Cash Flow Coverage Ratio
 5.44 4.99 3.12 3.09 5.82
Operating Cash Flow to Sales Ratio
 0.12 0.11 0.08 0.15 0.17
Free Cash Flow Yield
2.80%0.30%0.47%2.07%2.46%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 10.18 9.15 9.95 16.68 44.11
Price-to-Sales (P/S) Ratio
 2.36 2.13 2.41 4.89 5.96
Price-to-Book (P/B) Ratio
 1.03 0.93 1.00 2.04 2.53
Price-to-Free Cash Flow (P/FCF) Ratio
 35.72 333.81 214.47 48.34 40.59
Price-to-Operating Cash Flow Ratio
 20.05 19.64 30.14 32.64 34.81
Price-to-Earnings Growth (PEG) Ratio
 1.89 1.57 -0.90 0.24 -0.09
Price-to-Fair Value
 1.03 0.93 1.00 2.04 2.53
Enterprise Value Multiple
 4.98 3.95 4.10 9.33 21.76
Enterprise Value
 210.84M 168.78M 150.88M 503.52M 590.56M
EV to EBITDA
 4.98 3.95 4.10 9.33 21.76
EV to Sales
 1.17 0.94 0.92 3.27 4.32
EV to Free Cash Flow
 17.70 146.90 81.87 32.37 29.39
EV to Operating Cash Flow
 9.91 8.64 11.51 21.86 25.20
Tangible Book Value Per Share
 0.47 0.47 0.45 0.42 0.44
Shareholders’ Equity Per Share
 0.50 0.50 0.48 0.44 0.45
Tax and Other Ratios
Effective Tax Rate
 0.11 0.11 0.06 0.09 0.15
Revenue Per Share
 0.22 0.22 0.20 0.18 0.19
Net Income Per Share
 0.05 0.05 0.05 0.05 0.03
Tax Burden
 0.89 0.89 0.94 0.91 0.85
Interest Burden
 1.20 1.20 1.22 1.00 0.94
Research & Development to Revenue
 0.09 0.09 0.10 0.10 0.11
SG&A to Revenue
 0.38 0.37 0.38 0.12 0.16
Stock-Based Compensation to Revenue
 0.00 <0.01 0.00 0.00 <0.01
Income Quality
 0.51 0.41 0.31 0.51 1.08
Currency in USD